Registration Number
0221U103284,
0119U100658
, R & D reports
Title
To develop a new treatment for cryptosporidiosis of cattle, taking into account the peculiarities of the spread and pathogenesis
popup.stage_title
Head
Bogach Mykola V., Доктор ветеринарних наук
Registration Date
17-02-2021
Organization
National Scientific Center Institute of Experimental and Clinical Medicine
popup.description2
The extensitivity of drugs brovitacoccid and amprolev-plus in spontaneous cryptosporidiosis of calves was 80 and 90%, and tolkoktsid 2.5% - 60%.
Brovitacoccid and tolcoccid 2.5% were immunosuppressive for 21 days, while amprolev-plus for 14 days. A positive correlation between the content of leukocytes and the absolute number of lymphocytes indicates the activation of the immune cell.
Restoration of total protein, albumin and globulins, which became the basis for the formation of A / G coefficient was observed on the 14th day after setting amprolev-plus, and throughout the experiment there was a tendency to reduce the activity of ALT and AST enzymes and the concentration of circulating immune complexes, seromucoids, indicating a slight, compared with brovitakokcid, immunosuppressive effect of the drug.
Product Description
popup.authors
Bondarenko Liudmyla V
popup.nrat_date
2021-02-17
